Shalby1
Business description – Shalby Limited is one of the leading multi-specialty chain of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. As on the date of this Red Herring Prospectus, it provides inpatient and outpatient healthcare services through 11 operational hospitals with an aggregate bed capacity of 2,012 beds. As on 30 June 2017, the company had nine operational hospitals with an aggregate operational bed count of 841 beds. It had a 15% market share of all joint replacement surgeries conducted by private corporate hospitals in India in 2016. As on the date of this Red Herring Prospectus, the company also provides outpatient services through 47 Outpatient Clinics and has ten shared surgery centres within third party hospitals, which we call Shalby Arthroplasty Centre of Excellence (SACE), where it offers orthopaedic healthcare services including surgeries. Since March 2007, it has conducted an aggregate of 92,100 surgeries, and provided healthcare services to an aggregate of 1,025,533 patients, consisting 133,652 inpatients and 891,881 outpatients.

Headquartered in Ahmedabad, India, it has a domestic and overseas outreach through a network of hospitals in India, and Outpatient Clinics and SACE located in India, Africa, and the Middle East. Having strong presence in western and central India and focus on Tier – I and Tier – II cities, its hospitals operate across five states, Outpatient Clinics operate across 37 cities in 12 states in India, and SACE are present in seven cities in six states in India. Its international footprint consists five Outpatient Clinics and one SACE in Africa, and two SACE in the UAE. The company is expanding footprint in western and central India with hospitals being set up in Nashik and Vadodara.

Company Promoters:
The Promoters of our Company are Dr Vikram Shah, Dr Darshini Shah, Shanay Shah, Shah Family Trust, and Zodiac Mediquip Limited.
Dr Vikram Shah, Dr Darshini Shah, Shanay Shah, Shah Vikram Indrajit HUF and Shah Indrajit Chimanlal HUF are the promoters of Zodiac Mediquip Limited.
Company Financials:
Shalby2
Objects of the Issue:
The Offer comprises of the Fresh Issue and the Offer for Sale.
Company proposes to utilise the Net Proceeds from the Fresh Issue towards the following objects:
1. Repayment or prepayment in full, or in part of certain loans availed by the Company;
2. Purchase of medical equipment for existing, recently set up, and upcoming hospitals;
3. Purchase of interiors, furniture, and allied infrastructure for upcoming hospitals; and
4. General corporate purposes.
Company will not receive any proceeds from the Offer for Sale.
Issue Detail:
»» Issue Open: Dec 5, 2017 – Dec 7, 2017
»» Issue Type: Book Built Issue IPO
»» Issue Size:
› Fresh Issue of [.] Equity Shares of Rs 10 aggregating up to Rs 480.00 Cr
› Offer for Sale of 1,000,000 Equity Shares of Rs 10 aggregating up to Rs [.] Cr
»» Face Value: Rs 10 Per Equity Share
»» Issue Price: Rs 245 – Rs 248 Per Equity Share
»» Market Lot: 60 Shares
»» Minimum Order Quantity: 60 Shares
»» Listing At: BSE, NSE

Please contact us today for application at 033 40266300



New User?Register Now
×

Research Disclaimer

Proficient Equities Pvt. Ltd. is engaged in services of retail broking and shares research data and reports periodically with clients, investors, stakeholders and general public in compliance with SEBI Act, 1992, SEBI (Research Analysts) Regulations, 2014 and/or any other applicable directives, instructions or guidelines issued by the Regulators from time to time.

Proficient Equities Pvt. Ltd. (hereinafter referred to as “Proficient”) is a registered Member of NSE Limited, BSE Limited, MSEI Limited and its associate is member of MCX and NCDEX stock Exchange. It is also registered as a Depository Participant with CDSL.

Our research report is for your general information only and reproducing, re-circulating, publishing it in any media,website, in partial form or as a whole, without the express consent of Proficient Equities Pvt. Ltd. is prohibited. The
report is meant solely for use by the original recipient to whom it is sent. It does not take into account the particular investment objectives, financial situations, or needs of individual clients. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice/offer for the purpose of purchase or sale of any securities mentioned herein. Investor should rely on information/data arising out of their own investigations. Investors are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments.

Proficient or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. Proficient or its associates/ relatives neither has been debarred/suspended by SEBI or any other regulatory authority/exchange for accessing/ dealing in securities Market nor have any material conflict of interest. Proficient or its associates/ analyst have neither received any compensation from the company covered by Analyst during the past twelve months nor any subject company have been a client of Proficient during the past twelve months. Proficient or its associates has not received any compensation or other benefits from the company covered by analyst or third party in connection with the research report. The Analyst has not served as an officer, director or employee of company covered by Analyst and Proficient has not been engaged in market making activity of the company covered by Analyst.

The views expressed are based solely on information available publicly available/internal data/ other reliable sources believed to be true.Proficient does not represent/ provide any warranty express or implied to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before making any investment decision.

SEBI Research Analyst Reg. No. INH 300002498
Proficient Equities Pvt. Ltd.
×